You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Claims for Patent: 6,828,121

✉ Email this page to a colleague

Summary for Patent: 6,828,121

Title:	Bacterial host strains
Abstract:	An E. coli strain is described that is deficient in chromosomal degP and prc encoding protease DegP and Prc, respectively, and harbors a mutant spr gene that encodes a protein that suppresses growth phenotypes exhibited by strains harboring prc mutants. Preferably, the strain comprises nucleic acid encoding a polypeptide heterologous to the strain, so that a heterologous polypeptide can be produced therefrom.
Inventor(s):	Christina Yu-Ching Chen
Assignee:	Genentech Inc
Application Number:	US10/011,125

Details for Patent 6,828,121

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	LUCENTIS	ranibizumab	Injection	125156	June 30, 2006	⤷ Get Started Free	2021-12-07
Genentech, Inc.	LUCENTIS	ranibizumab	Injection	125156	August 10, 2012	⤷ Get Started Free	2021-12-07
Genentech, Inc.	LUCENTIS	ranibizumab	Injection	125156	October 13, 2016	⤷ Get Started Free	2021-12-07
Genentech, Inc.	LUCENTIS	ranibizumab	Injection	125156	March 20, 2018	⤷ Get Started Free	2021-12-07
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 6,828,121

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
South Africa	200304101	⤷ Get Started Free
World Intellectual Property Organization (WIPO)	0248376	⤷ Get Started Free
United States of America	2002142388	⤷ Get Started Free
Russian Federation	2287574	⤷ Get Started Free
Russian Federation	2003121232	⤷ Get Started Free
Poland	366194	⤷ Get Started Free
Poland	205897	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.